GlassScriptPhysician profile
Cheryl Warman
NPI 1356651178
$4,973.44
in general payments reported to CMS, 2019-2025
35 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $820 · 2023: $981 · 2024: $1,703 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,691.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $1,237.20 | 2021-2023 | |
| Aimmune Therapeutics, INC. | $675.23 | 2024-2025 | Zenpep |
| Astrazeneca Pharmaceuticals LP | $455.05 | 2021-2025 | Farxiga, Breztri, Lokelma |
| Abbvie INC. | $360.78 | 2021-2024 | |
| Lilly USA, LLC | $319.69 | 2022-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $274.47 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $232.19 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $175.19 | 2023-2025 | |
| Ardelyx, INC. | $153.24 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.29 | 2021-2025 | Trulance, Relistor |
| Otsuka America Pharmaceutical, INC. | $116.81 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Esperion Therapeutics, INC. | $69.47 | 2021-2025 | Nexletol |
| Currax Pharmaceuticals LLC | $60.90 | 2023-2024 | Onzetra Xsail, Contrave |
| Renalytix Ai, INC. | $59.46 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Pfizer INC. | $57.11 | 2023-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $51.85 | 2024 | |
| Glaxosmithkline, LLC. | $50.64 | 2021-2024 | Trelegy Ellipta |
| Astellas Pharma US INC | $46.51 | 2024-2025 | Veozah |
| Radius Health, INC. | $41.43 | 2024-2025 | Tymlos |
| Exact Sciences Corporation | $41.12 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.74 | 2024 | Jardiance |
| Antares Pharma, INC. | $36.90 | 2024-2025 | Xyosted |
| Ibsa Pharma INC. | $34.96 | 2024-2025 | Tirosint, Licart, Flector |
| Madrigal Pharmaceuticals | $30.19 | 2025 | Rezdiffra |
| Verity Pharmaceuticals INC. | $30.11 | 2025 | Tlando |
| Amgen INC. | $28.07 | 2025 | Otezla, Repatha |
| Corcept Therapeutics | $23.27 | 2024 | Korlym |
| Abbott Laboratories | $22.18 | 2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $22.01 | 2022 | |
| Recordati_rare_diseases_inc. | $21.93 | 2025 | Isturisa |
| Biohaven Pharmaceuticals, INC. | $19.43 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.77 | 2022 | |
| Shield Therapeutics INC | $18.10 | 2025 | |
| Axsome Therapeutics, INC. | $17.38 | 2025 | Sunosi |
| Edwards Lifesciences Corporation | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Warman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.